Celon Pharma S.A.

WSE:CLN.WA

15.96 (PLN) • At close December 14, 2023
Bedrijfsnaam Celon Pharma S.A.
Symbool CLN.WA
Munteenheid PLN
Prijs 15.96
Beurswaarde 814,861,740
Dividendpercentage 0.53%
52-weken bereik 13.1 - 18.4
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Dr. Maciej Wieczorek Ph.D.
Website https://www.celonpharma.com

An error occurred while fetching data.

Over Celon Pharma S.A.

Celon Pharma S.A., an integrated pharmaceutical company, researches, manufactures, and markets pharmaceutical products and preparations. The company operates through Generic Drug and Innovative segments. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon

Vergelijkbare Aandelen

Mercator Medical S.A. logo

Mercator Medical S.A.

MRC.WA

41.48 PLN

Ryvu Therapeutics S.A. logo

Ryvu Therapeutics S.A.

RVU.WA

64.5 PLN

Captor Therapeutics Spolka Akcyjna logo

Captor Therapeutics Spolka Akcyjna

CTX.WA

105 PLN

Mabion S.A. logo

Mabion S.A.

MAB.WA

19.28 PLN

BIOTON S.A. logo

BIOTON S.A.

BIO.WA

3.64 PLN

Selvita S.A. logo

Selvita S.A.

SLV.WA

59.7 PLN

Medicalgorithmics S.A. logo

Medicalgorithmics S.A.

MDG.WA

32.35 PLN

NEUCA S.A. logo

NEUCA S.A.

NEU.WA

843 PLN

Financiële Gegevens

Cijfers zijn in miljoenen (PLN)

Cijfers zijn in miljoenen (PLN)